CERO

We are advancing a CER T-cell platform that potentially offers novel approaches for the treatment of both hematologic malignancies and solid tumors... CERo's novel approach to fighting cancer aims to harness the power of the body's innate and adaptive immune systems... We are pioneering a new generation of autologous T-cell-based therapies that uniquely combine attributes of macrophages and dendritic cells of the innate immune system with those of T cells (adaptive immune system) for treatment of both hematologic and solid tumor cancers. This integrated approach draws on recent advances in synthetic and T cell biology with the intent to increase the curative potential and safety profile of current therapies.

Also known as: CERo Therapeutics, CERo Therapeutics, Inc.

Primary location: South San Francisco United States